Clinical Trial Update: Reduced Intensity Conditioning Using CD3+/CD19+ Depletion for Non Malignant Transplantable Diseases [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating reduced intensity conditioning using CD3+/CD19+ depletion for non-malignant transplantable diseases completed with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Marrow Failure Syndromes
• Immune Dysregulation Syndromes
• Immunodeficiencies

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Bone Marrow Failure Syndromes, Immunodeficiencies | Phase 2 | Status: COMPLETED | Results posted: 2018-04-11